Latest News On FDA

Latest KFF Health News Stories

KHN’s ‘What The Health?’: Despite Booming Economy, Uninsured Rate Ticks Up

KFF Health News Original

Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau’s annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and “surprise” medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.

Shopping Abroad For Cheaper Medication? Here’s What You Need To Know

KFF Health News Original

Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.

¿Buscas medicamentos más baratos en el exterior? Esto es lo que debes saber

KFF Health News Original

Los estadounidenses eluden la ley federal cruzando a Canadá y México, o recurriendo a farmacias en línea en el extranjero para comprar medicamentos recetados a una fracción del precio que pagarían en casa.

Tecnología casera ofrece más libertad a los pacientes para controlar su diabetes

KFF Health News Original

La diabetes tipo 1 es una condición crónica que requiere un estricto control de la glucosa y la administración de la cantidad de insulina precisa. Pacientes crearon un sistema para mantener ese equilibrio vital.

DIY Tech Gives People More Freedom In Managing Diabetes

KFF Health News Original

People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

KFF Health News Original

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

Prestigiosos hospitales se lanzan al negocio de terapias con células madre no aprobadas

KFF Health News Original

Los tratamientos típicos consisten en inyectar las articulaciones de los pacientes con sus propias células grasas o de médula ósea, o con extractos de plaquetas. No está comprobado científicamente que funcionen.